Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
This study is not yet open for participant recruitment.
Verified June 2011 by Tai Tien Pharmaceuticals Co., Ltd.
Study NCT01386853   Information provided by Tai Tien Pharmaceuticals Co., Ltd.

First Received on June 29, 2011.   Last Updated on June 30, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperlipidemia
Additional conditions recognized in this trial
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Pitavastatin
Atorvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Tai Tien Pharmaceuticals Co., Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services